Induction of apoptosis and reduction of MMP gene expression in the U373 cell line by polyphenolics in Aronia melanocarpa and by curcumin

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1435-1442

  Thani, Noor Azela Abdullah ^a   Sallis, Benjamin ^a   Nuttall, Robert ^b   Schubert, Frank R ^c   Ahsan, Mansoor ^c   Davies, Derek ^d   Purewal, Sukhveer ^d   Cooper, Alan ^c   Rooprai, Harcharan K ^a  

^a MIDDLESEX UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Apoptosis; Aronia melanocarpa; Curcumin; Glioblastoma; Matrix metalloproteinases; MTT

Indexed keywords

ANTINEOPLASTIC AGENT; ARONIA MELANOCARPA EXTRACT; CURCUMIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE 25; PLANT EXTRACT; POLYPHENOL DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRACE ELEMENT; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE INDUCTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MMP GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CURCUMIN; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INHIBITORY CONCENTRATION 50; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MATRIX METALLOPROTEINASES, SECRETED; PHOTINIA; PLANT EXTRACTS; POLYPHENOLS;

EID: 84866450116     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1941     Document Type: Article

References (41)

1. McKinney PA: Brain tumours: incidence, survival and aetiology. J Neurol Neurosurg Psychiatry 75: 1-12, 2004.
2. Egelblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nature Rev 2: 161-174, 2002.
3. Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20: 161-168, 2010.
4. Cauwe B, Van den Steen PE and Opdenakker G: The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42: 113-185, 2007.
5. Nuttal RK, Pennington CJ, Taplin J, Wheal A, Yong VW, Forsyth PA and Edwards DR: Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res 1: 333-345, 2003.
6. Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111-122, 1997.
7. Skrzydlewska E, Sulkowska M, Koda M and Sulkowski S: Proteolytic- antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol 11: 1251-1266, 2005.
8. Baker AH, Edwards DR and Murphy G: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115: 3719-3727, 2002.
9. Stupp R, Tonn JC, Brada M and Pentheroudakis G: High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21: V190-V193, 2010.
10. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J and Ram Z: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5: 79-88, 2003.
11. Weber EL and Goebel EA: Cerebral edema associated with gliadel wafers: two case studies. Neuro Oncol 7: 84-89, 2005.
12. Tapiero H, Tew KD, Nguyen Ba G and Mathe G: Polyphenols: do they play a role in the prevention of human pathologies? Biomed Pharmacother 56: 200-207, 2002.
13. Rooprai HK, Kandanearatchi A, Maidment SL, Christidou M, Trillo-Pazos G, Dexter DT, Rucklidge GJ, Widmer W and Pilkington GJ: Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol Appl Neurobiol 27: 29-39, 2001.
14. Rooprai HK, Christidou M and Pilkington GJ: The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas. Acta Neurochir (Wien) 145: 683-690, 2003.
15. Aggarwal BB, Kumar A and Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398, 2003.
16. Sharma RA, Gescher AJ and Steward WP: Curcumin: the story so far. Eur J Cancer 41: 1955-1968, 2005.
17. Datla KP, Zbarsky V and Dexter D: Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats. J Neural Transm 113: 583-591, 2006.
18. Pillai GR, Srivastava AS, Hassanein TI, Chauhan DP and Carrier E: Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208: 163-170, 2004.
19. Simon A, Allais DP, Durox JL, Basly JP, Durand-Fontainer S and Delage C: Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett 129: 111-116, 1998.
20. Shi M, Cai Q, Yao L, Mao Y, Ming Y and Ouyang G: Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int 30: 221-226, 2006.
21. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: an 'old-age' disease with an 'age-old' solution. Cancer Lett 267: 133-164, 2008.
22. Duvoix A, Roman B, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M and Diederich M: Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223: 181-190, 2005.
23. Anto RJ, Mukhopadhyay A, Dening K and Aggarwal BB: Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23: 143-150, 2002.
24. Larsen CA, Bisson WH and Dashwood RH: Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies. J Med Chem 52: 6543-6545, 2009.
25. Malik M, Zhao C, Schoene N, Guisti MM, Moyer MP and Magnuson BA: Anthocyanin-rich extract from Aronia meloncarpa E induces a cell cycle block in colon cancer but not normal colonic cells. Nutr Cancer 46: 186-196, 2003.
26. Zhao C, Giusti MM, Malik M, Moyer MP and Magnuson BA: Effects of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic colonic cell growth. J Agric Food Chem 52: 6122-6128, 2004.
27. Andress-Lacueva C, Shukitt-Hale B, Galli RL, Jaurengui O, Lamuela-Raventos RM and Joseph JA: Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8: 111-120, 2005.
28. Nikkah G, Tonn JC, Hoffmann O, Kraemer HP, Darling JL, Schahenmayr W and Schonmayr R: The MTT assay for chemosensitivity testing of human tumours of the central nervous system. J Neurooncol 13: 13-24, 1992.
29. Pennington CJ and Edwards DR: Real time PCR expression profiling of MMPs and TIMPs. Matrix Metalloproteinase Protocols. Methods Mol Biol 622: 159-173, 2010.
30. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184: 29-51, 1995.
31. Anand P, Kunnumakkara AB, Newman RA and Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818, 2007.
32. Zhang Y, Vareed SK and Nair MG: Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life Sci 76: 1465-1472, 2005.
33. Inagaki A, Soeda A, Oka N, Kitajima H, Nagakawa J, Motohashi T, Kunisada T and Iwama T: Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions. Biochem Biophys Res Commun 361: 586-592, 2007.
34. Szakacs G and Gottesman MM: Comparing solid tumours with cell lines: implications for identifying drug resistance genes in cancer. Mol Interv 4: 323-325, 2004.
35. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
36. Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004.
37. Saha A, Kuzuhara T, Echigo N, et al: Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of 'growth arrest and DNA damage inducible genes 45 and 153'. Biol Pharm Bull 33: 1291-1299, 2010.
38. Bill MA, Fuchs JR, Li C, et al: Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol Cancer Ther 8: 2726-2735, 2009.
39. Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H and Okada Y: Roles of membrane type 1 matrix metalloproteinases and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J Neurosurg 94: 464-473, 2001.
40. Sekine-Aizawa Y, Hama E, Watanabe K, Tsubuki S, Kanai-Azuma M, Kanai Y, Arai H, Aizawa H, Iwata N and Saido TC: Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum. Eur J Neurosci 13: 935-948, 2001.
41. Rooprai HK, Kyriazis I, Nuttall RK, Edwards DR, Zicha D, Aubyn D, Davies D, Gullan R and Pilkington GJ: Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol 30: 1263-1271, 2007.